Key Takeaways
- Advanced glycation end products form in the body and in cooked foods.
- High blood sugar and high heat both can raise AGE load.
- AGE buildup is linked with insulin resistance, inflammation, and vascular damage.
- The strongest diet concern centers on heavily browned and processed foods.
- Lower AGE meals often rely on gentler cooking and fewer packaged products.
What Are AGEs
Basic Idea
Advanced glycation end products, often called AGEs, are compounds that form when sugars bind to protein or fat and then change shape over time. This process is called glycation. It can happen inside the body, and it can also happen during cooking.
AGEs build faster when heat is high, cooking is dry, and food gets browned or charred. Roasting, grilling, frying, and searing can all raise AGE content. A lower heat method, such as steaming, poaching, stewing, or simmering, tends to create fewer of these compounds.
Body & Food Sources
The body makes AGEs during normal life, but higher blood sugar can speed the process. That helps explain why AGE research often overlaps with diabetes and insulin resistance.
A large review on diabetes markers found that higher dietary AGE intake was linked with worse fasting glucose, fasting insulin, and insulin resistance markers in pooled trial data (Lu, 2025). Food can add to the total load.
Processed foods and foods cooked to a dark crust often carry more AGEs than foods cooked with more water and less heat. That does not mean one meal causes disease on its own. It does suggest that steady exposure over many years may add stress in people who already have weak blood sugar control, kidney disease, or vascular disease.
Why Buildup Counts
AGEs are studied because they can alter how tissues work. They can stiffen proteins, affect blood vessels, and trigger cell signals tied to oxidative stress and inflammation. Oxidative stress means unstable molecules can damage cells. Inflammation means the immune system stays switched on when it should settle down.
A recent broad review described these same routes as common links between AGE buildup and damage across different organs, though much of that work still mixes human, animal, and lab findings (Zhang et al., 2025). That weakens any claim that AGEs alone drive chronic disease in every setting.
Disease Links
Blood Sugar Stress
The clearest human signal shows up around blood sugar control. Reviews of randomized trials have found that lower AGE diets can improve fasting insulin and insulin resistance in some groups, especially adults with metabolic risk or diabetes (Sohouli et al., 2021).
A double blind crossover trial in healthy adults with excess weight also found better insulin sensitivity during the lower AGE phase (de Courten et al., 2016).
That said, the evidence is not clean or uniform. A systematic review of trials in people with diabetes found a drop in circulating AGEs, but changes in glucose control were mixed and often small (Detopoulou et al., 2024). That means a lower AGE diet may help some metabolic markers without acting like a cure.
Heart & Vessel Risk
AGEs are also tied to heart and vessel disease. A meta analysis of prospective studies found that higher circulating AGE levels were associated with higher all cause and cardiovascular mortality (Sharifi-Zahabi et al., 2021).
Other cohort studies have linked skin autofluorescence, a rough marker of AGE buildup in tissue, with later cardiovascular events and death in people with peripheral artery disease, kidney disease, and type 2 diabetes.
These findings are important, but they still have limits. Association does not prove cause. People with higher AGE burden often also have higher blood sugar, poorer kidney function, more processed food intake, or more advanced disease. AGEs may act as both a marker of damage and part of the damage process.
Frailty & Kidney Strain
The kidney helps clear some AGE compounds, so kidney disease can raise the body burden. That may create a hard cycle where more AGEs and less clearance feed each other. In chronic kidney disease, higher AGE related skin readings have been linked with worse outcomes over time.
Frailty and disability in older adults have also been associated with higher AGE markers in blood. These links fit the idea that AGEs can affect tissue strength and recovery. Even so, most of this evidence is observational, which means it can show a pattern but cannot settle how much AGEs drive the process on their own.
Food Exposure
Cooking Style
For diet, the most useful point is simple. Dark, dry, high heat tends to make more AGEs. Moist, lower heat tends to make fewer. A grilled burger with a hard crust and crisp edges is likely to carry more AGEs than the same meat gently cooked in a stew.
That does not mean all animal foods are the issue. In practice, the cooking method often changes AGE load more than the food category alone. An animal based meal cooked slowly with broth may differ a great deal from the same cut cooked until deeply browned.
Processed Foods
Packaged foods can add another layer of concern because they often combine refined starch, sugar, industrial fats, and repeated high heat processing. That mix may increase both AGE content and blood sugar stress after eating.
Since the body also forms more AGEs when glucose stays high, heavily processed food may work from both ends. A crossover trial in healthy adults found that a lower AGE diet reduced markers tied to inflammation and cardiovascular risk compared with a higher AGE phase (Baye et al., 2017).
That does not prove every processed food harms every person, but it supports caution around foods built on browning, shelf life, and repeated heating.
What The Evidence Does Not Show
The evidence does not support fear around one single food or one single meal. It also does not prove that every chronic disease is mainly an AGE disease. Research quality still varies, study methods differ, and food AGE databases are imperfect.
A 2016 systematic review of randomized trials found some promising signals, but also noted inconsistency and study quality limits (Clarke et al., 2016). That is a good reason to stay measured. AGEs deserve attention, but not exaggeration.
Lowering The Load
Meal Structure
The best supported steps are practical and modest. A person can reduce AGE exposure by cutting back on ultra processed foods, avoiding frequent charring, and favoring meals cooked with water, broth, or lower heat. Whole cuts of meat, eggs, slow cooked stews, yogurt, kefir, and simple home cooked meals usually fit that goal better than crisp snack foods, sweet baked goods, or heavily browned fast food.
Stable blood sugar also likely helps because the body forms fewer AGEs when glucose stays in a healthier range. That gives extra weight to meals built around protein and fat rather than sugar and refined starch, especially in people with diabetes or insulin resistance.
Daily Cooking Choices
Small kitchen changes can make the plan easier:
- Cooking meats in a slow cooker, pressure cooker, soup, stew, or braise instead of frying to a dark crust.
- Choosing less packaged food and fewer sweet sauces, glazes, and baked snack foods.
- Using leftovers gently, rather than reheating until food dries out and browns again.
These steps do not remove all AGEs, nor should they be sold as a cure. They simply lower one avoidable source of metabolic stress while keeping food satisfying and simple.
A Balanced View
Chronic disease is never explained by one compound alone. Sleep, smoking, stress, body composition, blood sugar, kidney function, and overall diet quality all shape risk. AGEs appear to be one useful piece of that larger picture.
The strongest takeaway is not fear. It is that repeated high heat browning, processed food intake, and poor glucose control may work together over time. Lowering that combined load is a sensible goal, especially for people already dealing with diabetes, vascular disease, or kidney strain.
Before changing your diet, supplements, or health routine, talk with a licensed healthcare professional. For any health concerns or questions about a medical condition, get guidance from a physician or another appropriately trained clinician.
FAQs
What are advanced glycation end products?
Advanced glycation end products are compounds formed when sugar binds to protein or fat and changes them over time. They form inside the body and during high heat cooking.
Are advanced glycation end products bad for health?
Higher AGE levels are linked with several chronic diseases and worse metabolic health. The strongest concern is long term buildup, not one single meal.
Which foods are high in AGEs?
Foods cooked with dry, high heat often contain more AGEs. Fried foods, grilled foods, charred meats, baked sweets, and many processed foods tend to rank higher.
Can a person reduce AGE intake through diet?
A person can lower intake by using gentler cooking methods and eating fewer processed foods. Steaming, simmering, poaching, and stewing usually create fewer AGEs.
Do AGEs affect diabetes risk or control?
Research links higher AGE exposure with poorer insulin sensitivity and blood sugar markers in some studies. Results are mixed, but people with diabetes appear more vulnerable to AGE burden.
Related Posts
Research
Lu, X. et al. (2025) ‘Effect of dietary intake of advanced glycation end products on biomarkers of type 2 diabetes: a systematic review and meta-analysis’, Critical Reviews in Food Science and Nutrition. Available at: https://pubmed.ncbi.nlm.nih.gov/39320860/ (Accessed: 26 March 2026).
Zhang, Y. et al. (2025) ‘Advanced Glycation End Products in Disease: Pathophysiology, Clinical Significance, and Therapeutic Approaches’, Antioxidants, 14(4), p. 492. Available at: https://www.mdpi.com/2076-3921/14/4/492 (Accessed: 26 March 2026).
Sohouli, M.H. et al. (2021) ‘The Impact of Low Advanced Glycation End Products Diet on Metabolic Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials’, Advances in Nutrition, 12(3), pp. 766–776. Available at: https://pubmed.ncbi.nlm.nih.gov/33253361/ (Accessed: 26 March 2026).
de Courten, B. et al. (2016) ‘Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial’, American Journal of Clinical Nutrition, 103(6), pp. 1426–1433. Available at: https://pubmed.ncbi.nlm.nih.gov/27030534/ (Accessed: 26 March 2026).
Detopoulou, P. et al. (2024) ‘Dietary Restriction of Advanced Glycation End-Products (AGEs) in Patients with Diabetes: A Systematic Review of Randomized Controlled Trials’, International Journal of Molecular Sciences, 25(21), p. 11407. Available at: https://pubmed.ncbi.nlm.nih.gov/39518960/ (Accessed: 26 March 2026).
Sharifi-Zahabi, E. et al. (2021) ‘Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies’, Advances in Nutrition, 12(6), pp. 2157–2171. Available at: https://pubmed.ncbi.nlm.nih.gov/34139010/ (Accessed: 26 March 2026).
Baye, E. et al. (2017) ‘Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial’, Scientific Reports, 7(1), p. 4123. Available at: https://pubmed.ncbi.nlm.nih.gov/28646140/ (Accessed: 26 March 2026).
Clarke, R.E. et al. (2016) ‘Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials’, Nutrients, 8(3), p. 125. Available at: https://pubmed.ncbi.nlm.nih.gov/26938557/ (Accessed: 26 March 2026).
Sisay, M. et al. (2020) ‘The relationship between advanced glycation end products and gestational diabetes: A systematic review and meta-analysis’, PLoS One, 15(10), e0240382. Available at: https://pubmed.ncbi.nlm.nih.gov/33085688/ (Accessed: 26 March 2026).
Uribarri, J. et al. (2011) ‘Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1’, Diabetes Care, 34(7), pp. 1610–1616. Available at: https://pubmed.ncbi.nlm.nih.gov/21709297/ (Accessed: 26 March 2026).
Vlassara, H. et al. (2016) ‘Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial’, Diabetologia, 59(10), pp. 2181–2192. Available at: https://pubmed.ncbi.nlm.nih.gov/27468708/ (Accessed: 26 March 2026).
Goudarzi, R. et al. (2020) ‘Low advanced Glycation end product diet improves the central obesity, insulin resistance and inflammatory profiles in Iranian patients with metabolic syndrome: a randomized clinical trial’, Journal of Diabetes and Metabolic Disorders, 19(2), pp. 1129–1138. Available at: https://pubmed.ncbi.nlm.nih.gov/33520830/ (Accessed: 26 March 2026).
Kahleova, H. et al. (2022) ‘Dietary advanced glycation products and their associations with insulin sensitivity and body weight: A 16-week randomized clinical trial’, Obesity Science and Practice, 9(3), pp. 235–242. Available at: https://pubmed.ncbi.nlm.nih.gov/37287522/ (Accessed: 26 March 2026).
Linkens, A.M.A. et al. (2022) ‘A 4-Week Diet Low or High in Advanced Glycation Endproducts Has Limited Impact on Gut Microbial Composition in Abdominally Obese Individuals: The deAGEing Trial’, International Journal of Molecular Sciences, 23(10), p. 5328. Available at: https://pubmed.ncbi.nlm.nih.gov/35628138/ (Accessed: 26 March 2026).
Semba, R.D. et al. (2009) ‘Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults’, Journal of the American Geriatrics Society, 57(10), pp. 1874–1880. Available at: https://pubmed.ncbi.nlm.nih.gov/19682127/ (Accessed: 26 March 2026).
de Vos, L.C. et al. (2014) ‘Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease’, Arteriosclerosis, Thrombosis, and Vascular Biology, 34(4), pp. 933–938. Available at: https://pubmed.ncbi.nlm.nih.gov/24526694/ (Accessed: 26 March 2026).
Koska, J. et al. (2018) ‘Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes’, Diabetes Care, 41(3), pp. 570–576. Available at: https://pubmed.ncbi.nlm.nih.gov/29208654/ (Accessed: 26 March 2026).
Whitson, H.E. et al. (2014) ‘Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study’, Journals of Gerontology Series A, 69(6), pp. 710–716. Available at: https://pubmed.ncbi.nlm.nih.gov/24127427/ (Accessed: 26 March 2026).
Shardlow, A. et al. (2020) ‘The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study’, PLoS Medicine, 17(7), e1003163. Available at: https://pubmed.ncbi.nlm.nih.gov/32658890/ (Accessed: 26 March 2026).
Boersma, H.E. et al. (2021) ‘Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes’, BMC Endocrine Disorders, 21(1), p. 14. Available at: https://pubmed.ncbi.nlm.nih.gov/33435948/ (Accessed: 26 March 2026).
Forbes, J.M. et al. (2014) ‘Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects’, Amino Acids, 46(2), pp. 321–326. Available at: https://pubmed.ncbi.nlm.nih.gov/23832534/ (Accessed: 26 March 2026).
Semba, R.D. et al. (2011) ‘Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults’, Journal of Nutrition, 141(9), pp. 1726–1730. Available at: https://pubmed.ncbi.nlm.nih.gov/21775524/ (Accessed: 26 March 2026).
Botros, N. et al. (2017) ‘Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study’, Diabetes/Metabolism Research and Reviews, 33(5). Available at: https://pubmed.ncbi.nlm.nih.gov/28249105/ (Accessed: 26 March 2026).